(Q44525923)

English

Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy

scientific article published in August 2003

Statements

Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy (English)
P C Thuss-Patience

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit